v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net income (loss) $ 58 $ (4,400)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,074 1,005
Gain on sale of fixed assets (37) (82)
Non-cash interest 163 95
Stock-based compensation 758 910
Provision for reserve on accounts receivable 243 88
Provision for excess and obsolete inventory 541 259
Other (3) 3
Changes in operating assets and liabilities:    
Accounts receivable (3,114) (879)
Inventories (535) (2,195)
Prepaid and other assets 280 (376)
Accounts payable (890) 492
Accrued liabilities 2,740 (675)
Net cash provided by (used in) operating activities 1,278 (5,755)
Investing activities:    
Purchases of property and equipment (1,191) (773)
Proceeds from sale of fixed assets 48 99
Net cash used in investing activities (1,143) (674)
Financing activities:    
Payments on financing leases (17) (16)
Borrowings on line of credit 25,158 30,445
Repayments on line of credit (26,017) (24,797)
Debt issuance costs (34) (436)
Payment of taxes from withholding of common stock on settlement of restricted stock units (9) (17)
Net cash (used in) provided by financing activities (919) 5,179
Effect of exchange rate changes on cash and cash equivalents and restricted cash (2) (49)
Net change in cash and cash equivalents and restricted cash (786) (1,299)
Cash and cash equivalents and restricted cash at beginning of period 6,221 5,923
Cash and cash equivalents and restricted cash at end of period 5,435 4,624
Reconciliation of cash and cash equivalents and restricted cash reported in the condensed consolidated balance sheets    
Cash and cash equivalents 5,032 4,547
Restricted cash 403 77
Total cash and restricted cash reported in condensed consolidated balance sheets $ 5,435 $ 4,624